Statistics
Publications
6
Citations
493
H-Index
6
Active since
1996
Kelly Carles‐Kinch is an author at Duke Medical Center specializing in life sciences, cancer cell signaling, and antibody targeting ligands.
Publications per year
1996–2004
6
6
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Kelly Carles‐Kinch, Katherine E. Kilpatrick, Jane C. Stewart et al. · PubMed · 2002 · 199 citations
Medicine, Cell Biology, Oncology +17
Differential EphA2 epitope display on normal versus malignant cells.
Karen Coffman, Min Hu, Kelly Carles‐Kinch et al. · PubMed · 2003 · 106 citations
1–5 of 6